Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diltiazem 2% paste versus placebo for chronic anal fissure
2015-003627-54Phase 3Completed
- Sponsor
- Tecnimede
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic anal fissure (CAF) comparing Diltiazem 2% paste with Placebo (2 arms). Started Feb 2016; status: completed.
02
Drugs
diltiazem
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on 2015-003627-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003627-54.